EN
HI
Brawn Biotech Share price
23.07
0.11 (-0.47%)Last updated on 25 Aug, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Brawn Biotech share price chart
Brawn Biotech Share Key Metrics
Volume
985.00
Market Cap
6.92 CR
LTQ@LTP
883@23.07
ATP
22.97
Var Margin
53.5 %
Circuit Range
22.03-24.33
Delivery %
100 %
Value
22625.45
ASM/GSM
No
Market Lot
1
Summary
BRAWN stock price is ₹23.07 as of 25 Aug, 2026. The stock intraday movement has stayed between ₹22.10 and ₹23.15, while Brawn Biotech share price 52 week high low is ₹17.71 & ₹24.37.
In terms of trading activity, BRAWN share price has recorded a volume of 985 shares. The Brawn Biotech has a market cap of ₹3000300. The stock’s Average Traded Price (ATP) stands at ₹22.97, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 883 @ ₹23.07.
The Brawn Biotech upper circuit limit is ₹24.33 & The Brawn Biotech lower circuit limit is ₹22.03, with a Value of ₹22625.45. The Delivery Percentage for the day is 100%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Brawn Biotech Resistance and Support
Pivot 23.17
Resistance
First Resistance
23.19
Second Resistance
23.2
Third Resistance
23.22
Support
First Support
23.16
Second Support
23.14
Third Support
23.13
Brawn Biotech Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
52.94%
Mutual Fund
0.35%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
46.71%
Others
0%
Total Promoters
MAR '26
52.94%
JUN '26
52.94%
Brawn Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Brawn Biotech News
Brawn Biotech Ltd - 530207 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended June 30, 2026.
Brawn Biotech reported Q1 FY27 revenue of ₹6.08 crores (up 4.85% YoY) and net profit of ₹15.44 lakhs (down 34.6% YoY). The board also recommended M/s GDS M and Co as Statutory Auditors for five years and approved convening the 41st AGM on September 29, 2026.
Aug 13 2026 13:07:55
Brawn Biotech Ltd - 530207 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Brawn Biotech's Board is scheduled to meet on August 13, 2026, to consider and approve its Q1 FY27 financial results. The meeting focuses on the company's performance for the quarter ended June 30, 2026.
Aug 05 2026 16:57:45
Brawn Biotech Management
| Name | Position |
|---|---|
| Mayank Jain | Non Executive Independent Director |
| Pooja Jha | Non Executive Independent Director |
Brawn Biotech Similar Stocks
Diksha Greens Ltd.
0.93
-0.01 (1.06%)
Jayatma Enterprises Ltd.
28.55
0.00 (0.00%)
Worldwide Aluminium Ltd.
19.00
0.44 (2.37%)
Gratex Industries Ltd.
24.72
0.00 (0.00%)
Artemis ADR Marketplace Ltd.
101.55
0.00 (0.00%)
Amanaya Ventures Ltd.
14.55
0.00 (0.00%)
Padmanabh Industries Ltd.
8.94
0.18 (2.05%)
Olympic Cards Ltd.
2.77
0.01 (0.36%)
Brawn Biotech FAQs
The Buying Price of Brawn Biotech share is 23.07 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brawn Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brawn Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brawn Biotech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brawn Biotech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Brawn Biotech’s valuation compare Sector P/E, P/B which are 60.13 & 2.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brawn Biotech is 6.92 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brawn Biotech share price is 24.37 & 17.71. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brawn Biotech belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BRAWN
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC